Hai Li

662 total citations
19 papers, 356 citations indexed

About

Hai Li is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Hai Li has authored 19 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Hai Li's work include Cancer Treatment and Pharmacology (3 papers), Cancer Cells and Metastasis (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Hai Li is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Cancer Cells and Metastasis (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Hai Li collaborates with scholars based in China, United States and Italy. Hai Li's co-authors include Shikuo Rong, Nils Nickel, Kazuya Miyagawa, Lingli Wang, Quan Shang, Ashok K. Batta, Caiyun G. Li, Guorong Xu, Aiqin Cao and Jaya Bollineni and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and Metabolism.

In The Last Decade

Hai Li

19 papers receiving 353 citations

Peers

Hai Li
Hai Li
Citations per year, relative to Hai Li Hai Li (= 1×) peers Pengcheng Luo

Countries citing papers authored by Hai Li

Since Specialization
Citations

This map shows the geographic impact of Hai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Li more than expected).

Fields of papers citing papers by Hai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Li. The network helps show where Hai Li may publish in the future.

Co-authorship network of co-authors of Hai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Li. A scholar is included among the top collaborators of Hai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Li. Hai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Utkina-Sosunova, Irina, A Chiorazzi, Mariangels De Planell-Saguer, et al.. (2024). Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation. Scientific Reports. 14(1). 19341–19341. 3 indexed citations
2.
Wang, Weijie, et al.. (2024). A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11/GPX4 axis. Functional & Integrative Genomics. 24(4). 126–126. 3 indexed citations
5.
Wang, Xiangdong, et al.. (2022). Endovascular treatment for delayed post-pancreaticoduodenectomy hemorrhage of unusual origin (splenic artery branch). Journal of Vascular Surgery Cases and Innovative Techniques. 8(4). 865–871. 1 indexed citations
6.
Zhang, Xinhua, et al.. (2022). Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn. Translational Pediatrics. 11(9). 1544–1551. 4 indexed citations
7.
Dai, Huifang, et al.. (2020). Association between red blood cell distribution width and mortality in diabetic ketoacidosis. Journal of International Medical Research. 48(3). 1220711046–1220711046. 8 indexed citations
8.
Li, Hai, Yong Wang, Shikuo Rong, et al.. (2020). Integrin α1 promotes tumorigenicity and progressive capacity of colorectal cancer. International Journal of Biological Sciences. 16(5). 815–826. 36 indexed citations
10.
Tan, Lun, et al.. (2020). Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy.. PubMed. 13(2). 286–294. 8 indexed citations
11.
Li, Hai, Shikuo Rong, Chao Chen, et al.. (2018). Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells. Molecular Carcinogenesis. 58(2). 171–184. 17 indexed citations
13.
Zeng, Ping, Hai Li, Pei‐Hua Lu, et al.. (2017). Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis. Scientific Reports. 7(1). 4223–4223. 25 indexed citations
14.
Nickel, Nils, Edda Spiekerkoetter, Mingxia Gu, et al.. (2015). Elafin Reverses Pulmonary Hypertension via Caveolin-1–Dependent Bone Morphogenetic Protein Signaling. American Journal of Respiratory and Critical Care Medicine. 191(11). 1273–1286. 102 indexed citations
16.
Li, Hai, Xin Zhou, Jun Zhu, et al.. (2015). MiR-4728-3p could act as a marker of HER2 status. Cancer Biomarkers. 15(6). 807–814. 20 indexed citations
17.
Wu, Jian, Lei Fan, Yun He, et al.. (2012). Design, Synthesis and Multidrug Resistance Reversal Activity Evaluation of 8-Oxocoptisine Derivatives. Medicinal Chemistry. 8(4). 742–748. 4 indexed citations
18.
Shi, Yan, et al.. (2006). [Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].. PubMed. 25(8). 1039–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026